Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

Overview of attention for article published in Science, November 2010

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
twitter: 8 X users
patent: 15 patents

wikipedia: 5 Wikipedia pages
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 530 Mendeley
citeulike: 3 CiteULike

So far, Altmetric has seen 15 patents that reference this research output.

SETDB1 INHIBITOR FOR USE IN THE TREATMENT OF UVEAL MELANOMA

Application WO-2026013071-A1

World Intellectual Property Organisation (WIPO)

15 Jan 2026

Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma

Grant US-12365948-B2

United States of America

22 Jul 2025

Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma

Grant US-11434536-B2

United States of America

06 Sep 2022

BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

Application WO-2021130682-A2

World Intellectual Property Organisation (WIPO)

01 Jul 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 11 additional patents.